Ryan David Lake - 31 Dec 2021 Form 4 Insider Report for Recro Pharma, Inc.

Role
Chief Financial Officer
Signature
By: Ryan D. Lake
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
-$50,832
Form type
4
Filing time
04 Jan 2022, 20:34:48 UTC
Previous filing
17 Dec 2021
Next filing
19 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability $49,128 -28,730 -7.8% $1.71 339,965 31 Dec 2021 Direct F1
transaction SCTL Common Stock Tax liability $1,703 -979 -0.29% $1.74 338,986 03 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units.